between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D
agonist, as a model drug. Br J Clin Pharmacol 2003;56:537–544.
Kinzig-Schippers M, Tomalik-Scharte D, Jetter A, Scheidel B, Jakob V, Rodamer M,
Cascorbi I, Doroshyenko O, Sorgel F, Fuhr U. Should we use N-acetyltransferase
type 2 genotyping to personalize isoniazid doses?Antimicrob Agents Chemother
2005;49:1733–1738.
Klotz U, Schwab M, Treiber G. CYP2C19 polymorphism and proton pump inhibitors.
Basic Clin Pharmacol Toxicol 2004;95:2–8.
Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, Hines RN. Human hepatic flavin-
containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression.
Pediatric Res 2002;51:236–243.
Lake BG, Ball SE, Kao J, Renwick AB, Price RJ, Scatina JA. Metabolism of zaleplon
by human liver: evidence for involvement of aldehyde oxidase. Xenobiotica
2002;32:835–847.
Lawton MP, Cashman JR, Cresteil T, Dolphin CT, Elfarra AA, Hines RN, Hodgson E,
Kimura T, Ozols J, Phillips IR. A nomenclature for the mammalian flavin-
containing monooxygenase gene family based on amino acid sequence identities.
Arch Bioch Biophys 1994;308:254–257.
Lee CA, Kadwell SH, Kost TA, Serabjit-Singh CJ. CYP3A4 expressed by insect cells
infected with a recombinant baculovirus containing both CYP3A4 and human
NADPH-cytochrome P450 reductase is catalytically similar to human liver
microsomal CYP3 A4. Arch Biochem Biophys 1995;319:157–167.
Lessard E, Yessene MA, Hamelin BA, O’Hara G, LaBlanc J, Turgeon J. Influence of
CYP2D6 on the Disposition and Cardiovascular Toxicity of Antidepressent Agent
Venlafaxine in Humans. Pharmacogenetics 1999;9:435–443.
Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O.
Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase,
are present in human plasma. Biochem Pharmacol 2005;70:1673–1684.
McCracken NW, Blain PG, Williams FM. Human xenobiotic metabolizing esterases in
liver and blood. Biochem Pharmacol 1993;46:1125–1129.
Miners JO, McKinnon RA, Mackenzie PI. Genetic polymorphisms of UDP-
glucuronosyltransferases and their functional significance. Toxicology 2002;181–
182:453–456.
Muirhead GJ, Rance DJ, Walker DK, Wastall P. Comparative human pharmacoki-
netics and metabolism of single-dose oral and intravenous sildenafil. Br J Clin
Pharmacol 2002;53 (Suppl 1):13S–20S.
Nakamura H, Uetrecht J, Cribb AE, Miller MA, Zahid N, Hill J, Josephy PD,
Grant DM, Spielberg SP.In vitroformation, disposition and toxicity ofN-acetoxy-
sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity. J Pharmacol
Exp Ther 1995;274:1099–1104.
Obach RS. Nonspecific binding to microsomes: impact on scale-up ofin vitrointrinsic
clearance to hepatic clearance as assessed through examination of warfarin,
imipramine, and propranolol. Drug Metab Dispos 1997;25:1359–1369.
Obach RS. Prediction of human clearance of twenty-nine drugs from hepatic
microsomal intrinsic clearance data: An examination ofin vitrohalf-life approach
and nonspecific binding to microsomes. Drug Metab Dispos 1999;27:1350–1359.
REFERENCES 507